Home > Insider Trading > Casi Pharmaceuticals Inc. > Profile

Casi Pharmaceuticals Inc. (CASI)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Related Insiders

A Alexander Zukiwski, Evp And Chief Medical Officer, 2022-09-09
James Huang, Director, 2022-09-08
Wei-Wu He, Chairman And Ceo, 2022-06-17

A Alexander Zukiwski, Evp And Chief Medical Officer, 2022-09-09
James Huang, Director, 2022-09-08
Wei-Wu He, Chairman And Ceo, 2022-06-17
Quan Zhou, Director, 2022-05-26
Alexander Yue Wu, Director, 2022-05-26
Jr Cary Franklin Salisbury, Director, 2022-05-26
Md C Rajesh Shrotriya, Director, 2022-05-26
Larry Zhang, President, 2021-07-26
Weihao Xu, Chief Financial Officer, 2020-12-18
Ltd Holding Strategy Wealth, Large Shareholder, 2020-01-06
Keyong Ken Ren, Director, 2019-06-21
Spectrum Pharmaceuticals Cayman, L.p., Large Shareholder, 2019-04-04
Spectrum Pharmaceuticals Inc, Large Shareholder, 2019-04-04
Dapeng Li, Large Shareholder, 2019-02-06
W. Cynthia Hu, Coo, Gen Counsel & Secretary, 2019-02-01
Ltd Moon Snow, Large Shareholder, 2018-11-14
Hugo Shong, Large Shareholder, 2018-11-14
Dongliang Lin, Large Shareholder, 2018-11-14
Jianguang Li, Large Shareholder, 2018-11-14
Partnership) (Limited Center Management Jingran Tianjin, Large Shareholder, 2018-11-14
He Xie Ai Qi Investment Management (Beijing) Co., Ltd., Large Shareholder, 2018-11-14
Ltd Byte Sparkle, Large Shareholder, 2018-11-14
Fei Yang, Large Shareholder, 2018-11-14
George Chi, Chief Financial Officer, 2018-10-02
B Sara Capitelli, Vp Fin & Principal Account Off, 2018-07-13
Alex Wu, Director, 2018-07-03
L.p. Iii Fund Growth China Idg-Accel, Large Shareholder, 2018-03-23
Sing Chi Ho, Large Shareholder, 2018-03-23
L.p. Associates Iii Fund Growth China Idg-Accel, Large Shareholder, 2018-03-23
L.p. Investors Iii China Idg-Accel, Large Shareholder, 2018-03-23
Ltd. Associates Iii Gp Fund Growth China Idg-Accel, Large Shareholder, 2018-03-23
Suyang Zhang, Large Shareholder, 2016-06-30
W. Tak Mak, Director, 2016-03-04
Ken Ren, Ceo And Director, 2016-01-21
L Dwight Bush, Director, 2013-05-31
Jennie Cevera Hunter, Director, 2013-05-31
M C Mark Randall, Director, 2012-03-14
S Donald Brooks, Director, 2012-01-25
M Michael Tarnow, Director, 2012-01-25
F Carolyn Sidor, V.p. And Chief Medical Officer, 2011-01-12
R Mark Bray, Vice President, Research, 2011-01-12
S Peter Knight, Director, 2010-01-28

Show All Insiders (42)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on May 18, 2023, 12:45 pm based on SEC 13F filings Last update: May 18, 2023, 12:45 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Renaissance Technologies Jim Simons	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Huang Director	$4.28	33,300	$142,627.23	371,517	2022-09-08	Filing
Huang Director	$4.00	3,111	$12,433.11	338,217	2022-09-07	Filing
Huang Director	$3.89	19,162	$74,601.50	335,106	2022-09-06	Filing
Huang Director	$3.74	400	$1,496.52	315,944	2022-09-02	Filing
Huang Director	$3.72	11,821	$44,008.40	315,544	2022-09-01	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Value	% Port
1.	Proequities, Inc.PUT	$0	0%
2.	Proequities, Inc.CALL	$0	0%
3.	Proequities, Inc.	$0	0%

News See All

Click here to See All News